Platform & software · Enterprise imaging
Enterprise imaging and vendor neutral archive software: VNA vs PACS, and the vendors compared by layer
The short answer
Enterprise imaging is the strategy of managing every imaging study a health system produces in one place rather than in a separate departmental silo per specialty, and a vendor neutral archive (VNA) is the storage layer that makes it possible by holding studies in a standard format independent of the PACS that created them. The two are not interchangeable. A VNA is one layer of an enterprise imaging platform, alongside a universal viewer and the PACS itself, and the market ranks those layers separately. In the 2026 Best in KLAS awards announced February 4, 2026, Agfa HealthCare took three of them: Vendor Neutral Archive (VNA) at 89.8 percent, a second consecutive win, Universal Viewer (Imaging) with its XERO Viewer at 92.1 percent, a third consecutive win, and PACS (Small - under 300k studies) at 93.2 percent. Sectra took PACS above 300,000 studies a year for the thirteenth consecutive time. So there is no single best enterprise imaging platform, only a best answer for the specific layer you are replacing, and most buyers are replacing one layer, not all three.
The most expensive mistake in an enterprise imaging project is deciding what to buy before deciding which layer is broken.
Three different products get sold under the enterprise imaging heading. A vendor neutral archive stores the studies. A universal viewer displays them to everyone outside radiology, usually in a browser. The PACS is what radiologists actually read from. A vendor selling an enterprise imaging platform is selling all three as one purchase, and that is a legitimate product, but it is a much larger project than most sites need.
The clearest public evidence that these are separate markets is that the people who score them refuse to merge them. KLAS ranks vendor neutral archive, universal viewer and PACS as distinct categories, and PACS itself is split by annual study volume. Gartner Peer Insights went further and renamed its category to "Vendor-Neutral Archives (Transitioning to Enterprise Imaging Platforms)", which is an analyst firm saying out loud that the standalone archive is being absorbed into something bigger.
That absorption is the thing worth planning around. If you buy a VNA today from the same vendor that sells you the PACS and the viewer, you have bought convenience and given up the one property the VNA existed to give you, which is the ability to change PACS without moving the archive. That is not automatically the wrong trade. It is just a trade, and it is usually made without anyone naming it.
Cost follows the same layered shape. We pulled every federal prime contract award since October 2016 naming a vendor neutral archive and every award naming enterprise imaging, and the two sit an order of magnitude apart from the PACS platform figures. The tables below work through which layer you are in, who ranks first there, what the contract record suggests, and the one number that decides most VNA projects: what it costs to move your existing studies.
Last updated August 2026
Worklist
Structured report
DraftRun the assistant to draft this report for review.
Illustrative sample · not a real patient study, not a diagnosis
Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional judgment.
Flag · prioritize · draft · you review and sign
Decision support not a diagnosis
You review & sign
The archive sits underneath the reading platform, and the reading platform is covered separately in PACS software and PACS system vendors compared by study volume. The operational half of the same stack, meaning scheduling, worklists and billing, is radiology information system software, including how RIS and PACS divide the work. If the question is narrower, namely how an AI assistant reaches the reading station and returns anything to it, that is radiology AI PACS integration over DICOM and HL7.
On budget, radiology software pricing breaks federal contract data down by software category, and the contract terms worth negotiating covers renewal uplift and the fully loaded first-year total, which matter more on an archive deal than the license price does because you are signing up for years of storage growth. Groups reading across sites they do not control usually hit distribution before storage, which teleradiology software works through. For named vendors on the reporting side, see the radiology reporting software comparison and the radiology AI alternatives hub.
Side by side
Which enterprise imaging layer you are actually buying
Enterprise imaging is scored as separate layers, not as one product, and a different vendor can win each one. Decide which layer is failing before you take a platform demo, because the answer changes who belongs on the shortlist.
| What you are comparing | Vendor neutral archive (VNA) | Universal viewer | PACS | Full enterprise imaging platform |
|---|---|---|---|---|
| What it actually does | Stores studies in a standard format independent of the PACS that wrote them, so the archive survives a PACS change | Displays studies to everyone outside radiology, normally in a browser with nothing installed | Stores and displays studies for the radiologists who read them, with the reading tools attached | Sells all three as one product, plus the ingestion of non-DICOM specialties like dermatology and endoscopy |
| Who ranked first in the 2026 Best in KLAS awards | Agfa HealthCare Enterprise Imaging VNA, 89.8 percent, second consecutive year | Agfa HealthCare XERO Viewer, 92.1 percent, third consecutive year, in the Universal Viewer (Imaging) category | Sectra above 300,000 studies a year, thirteenth consecutive year; Agfa HealthCare at 93.2 percent in PACS (Small - under 300k studies); INFINITT in ambulatory and community | No single KLAS category exists for the bundle, which is the point: you are buying three separately ranked things at once |
| The problem it is bought to solve | Migration pain and vendor lock-in, usually discovered during the last PACS replacement | Clinicians outside radiology cannot see images without a PACS seat | Radiologists need faster reading, better hanging protocols or a supported product | Multiple departmental silos, each with its own archive, and no single patient imaging record |
| What the federal contract record shows | 7 prime awards name "vendor neutral archive", totaling $1,109,975, median $89,347, 75th percentile $186,639 | 4 prime awards name "enterprise imaging", totaling $1,501,526, median $427,074, and Agfa HealthCare holds $1,036,658 of that | Awards naming "picture archiving and communication" total $68,836,793 across 48 awards, median $250,438 | Platform deals do not label themselves; they surface under the PACS terms, which is why the PACS median is roughly triple the VNA median |
| Who actually holds the contract | An integrator more often than a vendor: Thundercat Technology leads at $509,222, ahead of Alvarez LLC at $331,437 and Aycan Medical Systems at $269,316 | Agfa HealthCare at $1,036,658 and Open Text at $464,868 lead the enterprise imaging term outright | Four Points Technology holds $16,122,656, ahead of Philips Healthcare Informatics at $13,050,750 | Expect a reseller on the paper, which changes who holds discount authority and who you escalate to |
| What the migration costs | The number that decides the project. Commonly quoted industry rates run about $0.05 to $0.50 per study depending on how proprietary the source format is, so an 18,000-study archive lands near $900 to $9,000 and decades of accumulated imaging runs well past $40,000 | Little to none; a viewer reads from the archive rather than holding its own copy | Migration is the reason PACS replacements slip, and it is the cost a VNA is bought to avoid repeating | Paid once at consolidation, then in principle never again, which is the whole financial argument for the bundle |
| The lock-in question nobody asks out loud | If the VNA comes from your PACS vendor, you have bought convenience and given back the neutrality you were paying for. Ask what a competitor migration would cost in writing | Whether referring physicians keep access if the viewer vendor changes | What bulk DICOM export costs without a professional services engagement | Concentration risk: one vendor now owns storage, display and reading, so any future change touches all three at once |
| When you genuinely need it | You run more than one PACS, you expect to switch PACS, or a regulator or health system partner requires you to hold the data yourself | Anyone outside radiology needs routine image access, which is most sites the moment referrers ask | Always, if radiologists read on site. This is the layer you cannot skip | Multiple imaging-producing departments and an IT team large enough to run a multi-year consolidation |
| Where an AI assistant attaches | Not here. An assistant reads current studies from the reading path, not from cold archive storage | Not here. The viewer displays; it does not analyze | Here. Radiological.ai reads the study, flags suspected findings for a second look and reorders the worklist | Here, through the PACS layer, and it attaches once centrally rather than per department |
| Regulatory status | Storage software; no diagnostic claim attaches to an archive | Some viewers carry their own FDA clearances for diagnostic display and some are explicitly for reference only, so confirm which you are buying | Diagnostic viewers within PACS carry their own clearances | Decision support in our case; we make no regulatory-status claims on this site |
Compiled August 2026. Best in KLAS placements and scores are from the 2026 awards announced February 4, 2026, as stated in Agfa HealthCare's own release and reported by Radiology Business; category names are KLAS category names quoted as published. Contract figures are prime awards from the USAspending.gov API, award type codes A, B, C and D, award start dates from October 1 2016 through August 24 2026, searched on the exact keyword shown. Keyword matching on USAspending is literal, so these figures are a floor rather than a full market picture, and per-award statistics drift slightly between pulls while totals stay stable. Migration rates are commonly quoted industry ranges rather than measured figures, so treat them as a sanity check on a quote, not as a price. Vendor names are examples of who sells into each layer and are not an endorsement or a shortlist.
Why it works
What your group gets with enterprise imaging
Name the failing layer before the first demo
The scoreboards for this market are deliberately split into vendor neutral archive, universal viewer and PACS, and PACS is split again by study volume. A platform demo blurs all of that back together. Decide first whether your actual problem is storage, outside-radiology access or the reading experience, because that answer changes the shortlist entirely and it is the only way to compare quotes that are not comparing the same thing.
A VNA from your PACS vendor is a trade, not a purchase
The point of a vendor neutral archive is that you can change PACS without moving the archive. Buying it from the PACS vendor is convenient, cheaper to integrate and frequently the right call at smaller scale, but it hands back the exact property you were paying for. Make the trade knowingly: ask, in writing, what migrating to a competitor would cost and how long it would take.
AI attaches to the reading path, not to the archive
Radiological.ai works alongside whatever archive and PACS you land on. It reads the study, flags suspected findings for a second look, pushes urgent studies up the worklist and drafts the structured report into your template. It is decision support, not a viewer and not an archive, and the responsible radiologist reviews, edits and signs every study.
What it handles
Flagged, prioritized and drafted for your review
The assistant pre-reads each study, surfaces a region of interest for review, re-prioritizes the worklist, and drafts the structured report in your template. You confirm, edit and sign.
- Works with your existing PACS and archive rather than replacing either
- Connects over standard DICOM and HL7 interfaces
- Flags suspected findings for a second look
- Reorders the worklist so urgent studies surface first
- Drafts the structured report into your template
- Attaches once centrally instead of per department or per site
- Radiologist reviews, edits and signs every study
Region of interest flagged for review
A focal region is surfaced on the sample study for the radiologist to review. The assistant does not characterize it as a diagnosis.
Suspected finding flagged for radiologist review. Correlate clinically and confirm. Draft for review and sign-off.
Why Radiological.ai
One assistant across the whole read
Not three vendors stitched together. Flag, prioritize and draft in one calm pane, on X-ray, CT and MRI, with the radiologist signing every study.
Flags suspected findings
A second set of eyes surfaces regions of interest for review on every study, so a suspected finding is less likely to slip past late in a shift.
Prioritizes the worklist
Suspected-critical studies move to the top, so urgent reads surface ahead of routine follow-ups across your sites and shifts.
Drafts the report
A structured draft arrives in your template, ready to edit and sign. The draft saves the typing and the measuring, never the judgment.
Good questions
Questions about enterprise imaging
Explore more
More ways teams read with Radiological.ai
Radiology AI platform
One assistant across the whole read, not three point tools stitched together.
Learn moreAI medical imaging
A workflow assistant for the imaging your team reads every day.
Learn moreAI radiology assistant
An assistant that reads alongside you and drafts before you sit down.
Learn moreFrom the blog: best AI radiology software in 2026, how much radiology AI costs, how to implement AI in a radiology workflow, and AI radiology companies.
Read more studies, with the assistant alongside you
Flag suspected findings, prioritize the worklist, and draft the structured report. You review and sign every study.
Radiological.ai is a workflow and decision-support tool for qualified clinicians. It does not provide a diagnosis and is not a substitute for professional medical judgment.